Turner M J, Keane D P, Flannelly G M, Lenehan P M, Murphy J F, Foley M E
Department of Obstetrics and Gynaecology, National Maternity Hospital, Dublin.
Ir Med J. 1990 Jun;83(2):61-2.
The value of population screening for cervical cancer has recently been questioned. The purpose of this study was to examine the cytological screening history in 100 consecutive patients undergoing Wertheim's hysterectomy for early invasive cervical cancer. Twenty three per cent of the patients were never screened; the screening history was unavailable in 11%; the patient was referred appropriately in 21%; there was a delay in referral for gynaecological assessment in 21%; the patient's previous cervical smear before referral was normal in 24%. If population screening in Ireland is to have an impact on mortality from cervical cancer, the results of this study indicate that greater attention needs to be given not only to extending the number of women screened, but also to increasing the frequency of screening and to improving the clinical response to an abnormal smear.
近期,针对宫颈癌进行人群筛查的价值受到了质疑。本研究旨在调查100例因早期浸润性宫颈癌接受韦特海姆子宫切除术的连续患者的细胞学筛查史。23%的患者从未接受过筛查;11%的患者筛查史不详;21%的患者转诊恰当;21%的患者转诊进行妇科评估存在延迟;24%的患者转诊前的宫颈涂片结果正常。如果爱尔兰的人群筛查要对宫颈癌死亡率产生影响,本研究结果表明,不仅需要更加关注扩大接受筛查的女性数量,还需要增加筛查频率,并改善对异常涂片的临床反应。